Changfeng Pharmecuetical (02652.HK) suggests adopting an H-share incentive plan.

Zhixun financial APP, Changfeng Pharmaceutical (02652.HK) announced that on November 12, 2025, it has decided to adopt the company's 2025 H-share incentive trust plan. The H-share incentive plan aims to align the interests of employees, management and shareholders of the company, attract, retain and motivate key talents, reward their contributions, and promote the company's sustainable development and long-term success.